TSPAN6 and neoplasm: TSPAN6 expression indeed differentiated between the EMT and epithelial NSCLC tumor subgroups, with high TSPAN6 expression being associated with an epithelial signature (Fig. 7a), which correlates with better therapy response and overall patient survival [36].